Regression of brain metastases of renal cell carcinoma with antiangiogenic therapy [3]

Journal of Neuro-Oncology

Volumn 86, Issue 2, 2008, Pages 243-244

  Thibault, Frédéric ^a   Billemont, Bertrand ^a   Rixe, Olivier ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; SUNITINIB;

ADULT; BONE METASTASIS; BRAIN METASTASIS; CANCER REGRESSION; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; LETTER; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; STEREOTAXIC SURGERY; TREATMENT OUTCOME; TUMOR VOLUME;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INDOLES; KIDNEY NEOPLASMS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PYRROLES; TREATMENT OUTCOME;

EID: 37249035965     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9449-5     Document Type: Letter

References (5)

1. Rini BI, Small EJ (2005) Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma. J Clin Oncol 23:1028-1043
2. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA. (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356(2):115-124
3. Peacock KH, Lesser GJ (2006) Current therapeutic approaches in patients with brain metastases. Curr Treat Options Oncol 7:479-489
4. Doolittle ND, Abrey LE, Bleyer WA et al (2005) New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting. Clin Cancer Re 11: 421
5. Zhang ZG, Zhang L, Jiang Q et al (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106: 829